Sterling Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$7.23K	Buy	517 +121	+31%	+$1.69K	﹤0.01%	2313
2025 Q1	$5.34K	Sell	396 -271	-41%	-$3.65K	﹤0.01%	2139
2024 Q4	$12.8K	Buy	667 +567	+567%	+$10.9K	﹤0.01%	2053
2024 Q3	$2.28K	Buy	+100	New	+$2.28K	﹤0.01%	2128